GREAT POINT PARTNERS LLC - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 62 filers reported holding ACUMEN PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,457,519
-11.8%
1,074,101
+2.2%
0.81%
-18.0%
Q2 2023$5,056,594
+18.5%
1,051,2670.0%0.99%
+18.1%
Q1 2023$4,268,144
-29.2%
1,051,267
-5.8%
0.84%
-29.1%
Q4 2022$6,029,537
-49.9%
1,116,581
-7.0%
1.18%
-59.2%
Q3 2022$12,036,000
+69.0%
1,200,000
-20.8%
2.90%
+69.7%
Q2 2022$7,121,000
+96.2%
1,515,000
+63.2%
1.71%
+94.8%
Q1 2022$3,630,000928,2820.88%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders